2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone has been researched along with Thrombocytopenia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Case, DC; Hayes, DM | 1 |
Griffin, JP; Krakoff, IH; McCormack, JJ; Newman, RA | 1 |
Bedikian, AY; Bodey, GP; Burgess, MA; Yap, BS | 1 |
Bedikian, AY; Bodey, GP; Burgess, MA; Freireich, EJ | 1 |
Aisner, J; Budman, DA; Shulman, P; Sigman, LM; Van Echo, DA; Whitacre, MY | 1 |
5 other study(ies) available for 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone and Thrombocytopenia
Article | Year |
---|---|
Phase II study of aziridinylbenzoquinone in refractory lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Azirines; Benzoquinones; Bone Marrow; Cyclohexenes; Drug Evaluation; Drug Resistance; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Thrombocytopenia | 1983 |
Clinical and clinical pharmacologic studies of aziridinylbenzoquinone.
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Cyclohexenes; Drug Evaluation; Female; Half-Life; Humans; Kinetics; Leukopenia; Male; Middle Aged; Neoplasms; Thrombocytopenia | 1982 |
AZQ therapy in patients with disseminated malignant melanoma.
Topics: Adult; Aged; Anorexia; Aziridines; Azirines; Benzoquinones; Bone Marrow; Cyclohexenes; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Nausea; Thrombocytopenia; Vomiting | 1982 |
Phase I study of aziridinylbenzoquinone (NSC 182986).
Topics: Adult; Aged; Anemia; Aziridines; Azirines; Benzoquinones; Bone Marrow; Cyclohexenes; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Stomatitis; Thrombocytopenia; Vomiting | 1981 |
Phase I trial of 5-day continuous infusion aziridinylbenzoquinone (AZQ, diazaquone, NSC 182968).
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Cyclohexenes; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Thrombocytopenia | 1986 |